| About This Archive | | DCHAS-L 2016 Index | | DCHAS-L Yearly Index | |
Check out Safety Emporium for your N95, N99, and face shield needs.
|
Previous by Date: Subject: [DCHAS-L] ACS Strategic Plan Date: Thursday, February 11, 2016 10:55:18 AM Author: Frankie Wood-Black <fwblack**At_Symbol_Here**CABLEONE.NET> |
Next by Date: Subject: [DCHAS-L] Comments sought: NIOSH CIB on nanosilver Date: Thu, 11 Feb 2016 15:00:54 -0500 Author: "Secretary, ACS Division of Chemical Health and Safety" |
This may be of interest to people involved in work with high toxicity dusts...
- Ralph
SUMMARY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) requests information for the development of a test protocol to evaluate the performance of closed system drug-transfer devices (CSTDs) that adopt air-cleaning technologies. CSTDs are generally available in two design types:
(1) One that uses a physical barrier to block the unintended release of drug into the surrounding environment or the intake of environmental contaminants into the sterile drug pathway and
(2) one that uses air cleaning or filtration technologies to prevent the unintended release of drug into the surrounding environment or the intake of environmental contaminants into the sterile drug pathway.
A draft protocol titled, A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs (see link below), was developed by NIOSH to evaluate how protective the physical barrier-type CSTD devices were as an indicator of how effective they would be at preventing hazardous drug escape from the closed system.
This RFI seeks information from the public regarding the feasibility of developing a protocol applicable to CSTDs using air cleaning or filtration technologies and to request information from stakeholders on this topic.
Previous post | Top of Page | Next post